NCT06786819 Impact of a Technology Platform Based on Enhanced Recovery After(ERAS) Surgery on Length of Stay After Coronary Artery Bypass Grafting: Timely Project
| NCT ID | NCT06786819 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Sao Paulo General Hospital |
| Condition | ERAS |
| Study Type | INTERVENTIONAL |
| Enrollment | 480 participants |
| Start Date | 2025-03-10 |
| Primary Completion | 2026-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 480 participants in total. It began in 2025-03-10 with a primary completion date of 2026-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Cardiovascular diseases continue to be the leading cause of death worldwide. Among them, coronary artery disease has the greatest impact, being characterized as one of the main causes of death in Brazil over the last decade. One of the well-established treatments is coronary artery bypass grafting, which is the most performed among cardiac surgeries and, in our scenario, is primarily funded by the Unified Health System (SUS). The information obtained from the Paulista Registry of Cardiovascular Surgeries (REPLICCAR), in partnership with FAPESP, has been important for implementing improvements in the landscape of cardiac surgeries in the state of São Paulo. Although outcomes in cardiac surgery have improved due to the structuring and organization of quality programs, this is still not a reality at the national level. In a situation where data collection and quality initiatives play a central role in continuous improvement, generating value becomes essential for the sustainability of cardiac surgery programs. In this sense, the concept of Enhanced Recovery After Surgery (ERAS) has gained increasing traction. This concept is based on multidisciplinary protocols and scientific evidence, which help prepare patients for rapid recovery, resulting in reduced complications, shorter hospital stays, and, primarily, lower hospital costs. On the other hand, the increase in surgical waiting lists has also led to a rise in home mortality due to cardiac causes. Thus, among the various challenges imposed by the current scenario, the investigators believe that preparing patients for rapid recovery after coronary artery bypass grafting presents an opportunity for the sustainability of the healthcare system. Therefore, the aim of this project is to evaluate the impact of a technology platform based on ERAS on the postoperative recovery time of patients undergoing coronary artery bypass grafting in reference centers in the state of São Paulo, Timely Project - REPLICCAR III.
Eligibility Criteria
Inclusion Criteria: * Adults over 18 years old * Indication for primary isolated CABG (elective or urgent status) * Own a personal cell phone * Have internet access * Knowledgeable in using the device * Full understanding and agreement regarding the informed consent form (ICF) Exclusion Criteria: * Indication for associated surgery * Glycosylated hemoglobin level greater than 8% * Creatinine clearance less than 30 mL/min * Pre-operative atrial fibrillation or use of pre-operative anticoagulation * Hemoglobin less than 12 g/dL * Users of illicit drugs * STS score greater than 4% * Physical or mental disabilities that prevent adherence to the protocol * Refusal by the patient or family member
Contact & Investigator
Omar A V Mejia, MD, PhD
PRINCIPAL INVESTIGATOR
InCor - Instituto do Coração do Hospital das Clínicas da FMUSP
Frequently Asked Questions
Who can join the NCT06786819 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying ERAS. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06786819 currently recruiting?
Yes, NCT06786819 is actively recruiting participants. Contact the research team at omarvmejia@incor.usp.br for enrollment information.
Where is the NCT06786819 trial being conducted?
This trial is being conducted at São Paulo, Brazil, São Paulo, Brazil.
Who is sponsoring the NCT06786819 clinical trial?
NCT06786819 is sponsored by University of Sao Paulo General Hospital. The principal investigator is Omar A V Mejia, MD, PhD at InCor - Instituto do Coração do Hospital das Clínicas da FMUSP. The trial plans to enroll 480 participants.